Novo Nordisk A/S Class B's inventory is $51B.
Get informed when a big investor buys or sells
+ FollowLatest change versus the prior comparable period (same company).
As of the most recent data (June 2026), NONOF shows a inventory of $51B. That compares with $46B in the prior-year period — up 12.5% year over year. Scroll down for historical charts and peer comparison views.
Compared with the year-ago period, NONOF's inventory is now $51B (was $46B) — a 12.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Novo Nordisk A/S Class B is outperforming or lagging.
Tracking NONOF's inventory over time shows whether Novo Nordisk A/S Class B is scaling, shrinking, or reshaping that part of the business. The current reading is $51B That compares with $46B in the prior-year period — up 12.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.
Besides this inventory page, Stockcircle has Novo Nordisk A/S Class B's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect inventory (currently $51B) with ownership activity and broader fundamentals.
Novo Nordisk A/S Class B's inventory is $51B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.